Unresolved issues in early trials of cholesterol loweringLAROSA, J. C.The American journal of cardiology. 1995, Vol 76, Num 9, pp 5C-9C, issn 0002-9149Conference Paper

Cholesterol-lowering trials : new results and emerging issues. SymposiumSACKS, Frank M; PFERRER, Marc A; BRAUNWALD, Eugene et al.The American journal of cardiology. 1995, Vol 76, Num 9, issn 0002-9149, 131 p.Conference Proceedings

Lipid-lowering interventions in angiographic trialsROSSOUW, J. E.The American journal of cardiology. 1995, Vol 76, Num 9, pp 86C-92C, issn 0002-9149Conference Paper

Cholesterol reduction and its impact on coronary artery disease and total mortalityHOLME, I.The American journal of cardiology. 1995, Vol 76, Num 9, pp 10C-17C, issn 0002-9149Conference Paper

Elucidation of the role of plaque instability and rupture in acute coronary eventsFUSTER, V.The American journal of cardiology. 1995, Vol 76, Num 9, pp 24C-33C, issn 0002-9149Conference Paper

Reduction in coronary events during treatment with pravastatinFURBERG, C. D; PITT, B; BYINGTON, R. P et al.The American journal of cardiology. 1995, Vol 76, Num 9, pp 60C-63C, issn 0002-9149Conference Paper

Results of the primary outcome measure and clinical events from the asymptomatic carotid artery progression studyPROBSTFIELD, J. L; MARGITIC, S. E; BYINGTON, R. P et al.The American journal of cardiology. 1995, Vol 76, Num 9, pp 47C-53C, issn 0002-9149Conference Paper

What benefit can be derived from treating normocholesterolemic patients with coronary artery disease ?BROWN, B. G; STEWART, B. F; XUE-QIAO ZHAO et al.The American journal of cardiology. 1995, Vol 76, Num 9, pp 93C-97C, issn 0002-9149Conference Paper

Cholesterol and recurrent events : a secondary prevention trial for normolipidemic patientsPFEFFER, M. A; SACKS, F. M; COLE, T. G et al.The American journal of cardiology. 1995, Vol 76, Num 9, pp 98C-106C, issn 0002-9149Conference Paper

Range of serum cholesterol values in the population developing coronary artery diseaseKANNEL, W. B.The American journal of cardiology. 1995, Vol 76, Num 9, pp 69C-77C, issn 0002-9149Conference Paper

Prospective meta-analysis of cholesterol-lowering studies : the prospective pravastatin pooling (PPP) project and the cholesterol treatment trialists (CTT) collaborationSIMES, R. J.The American journal of cardiology. 1995, Vol 76, Num 9, pp 122C-126C, issn 0002-9149Conference Paper

The influence of pretreatment low density lipoprotein cholesterol concentrations on the effect of hypocholesterolemic therapy on coronary atherosclerosis in angiographic trialsSACKS, F. M; GIBSON, C. M; ROSNER, B et al.The American journal of cardiology. 1995, Vol 76, Num 9, pp 78C-85C, issn 0002-9149Conference Paper

Effect of pravastatin on progression and regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries : a report from the regression growth evaluation statin studyDE GROOT, E; JUKEMA, J. W; VAN BOVEN, A. J et al.The American journal of cardiology. 1995, Vol 76, Num 9, pp 40C-46C, issn 0002-9149Conference Paper

Trials and tribulations : Emerging issues in designing economic evaluations alongside clinical trialsCOYLE, D; DAVIES, L; DRUMMOND, M. F et al.International journal of technology assessment in health care. 1998, Vol 14, Num 1, pp 135-144, issn 0266-4623Article

Contrasting Bayesian analysis of survey data and clinical trialsMALEC, Donald J.Statistics in medicine. 2001, Vol 20, Num 9-10, pp 1363-1371, issn 0277-6715Conference Paper

Statistical models appropriate for designs often used in group-randomized trialsMURRAY, David M.Statistics in medicine. 2001, Vol 20, Num 9-10, pp 1373-1385, issn 0277-6715Conference Paper

Acute coronary syndromes and diabetes : is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trialAHMED, Shaheeda; CANNON, Christopher P; MURPHY, Sabina A et al.European heart journal. 2006, Vol 27, Num 19, pp 2323-2329, issn 0195-668X, 7 p.Article

Recent trials of lipid loweringRAY, K. K; CANNON, C. P; BRAUNWALD, E et al.International journal of clinical practice (Esher). 2007, Vol 61, Num 7, pp 1145-1159, issn 1368-5031, 15 p.Article

State-of-the-art update and review : Clinical trials of lipid-lowering agentsKWITEROVICH, P. O.The American journal of cardiology. 1998, Vol 82, Num 12A, pp 3U-17U, issn 0002-9149Conference Paper

The emerging role of cytochrome P450 3A in psychopharmacologyKETTER, T. A; FLOCKHART, D. A; POST, R. M et al.Journal of clinical psychopharmacology. 1995, Vol 15, Num 6, pp 387-398, issn 0271-0749Article

Time to benefit in lipid-lowering trialsBRAUNWALD, Eugene; GOTTO, Antonio M.The American journal of cardiology. 2005, Vol 96, Num 5, issn 0002-9149, 81 p., SUPConference Proceedings

Clinical trial results with a new plasminogen activatorBODE, C; PETER, K; MOSER, M et al.European heart journal. 1997, Vol 18, Num DEC, pp F17-F21, issn 0195-668X, SUPFConference Paper

Emerging issues = Issues de secoursWELCH, T.The Construction specifier. 1991, Vol 44, Num 8, pp 120-126, issn 0010-6925Article

Ongoing and emerging issuesKAMERMAN, S. B; KAHN, A. J.Children and youth services review. 1990, Vol 12, Num 1-2, pp 91-112, issn 0190-7409, 22 p.Article

Transportation emerging research issuesHAEFNER, L. E.Civil engineering for practicing and design engineers. 1986, Vol 5, Num 1, pp 29-34, issn 0277-3775Article